HighCape Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Modifi Biosciencesmodifibio.comin𝕏Aug 2024 · $4.3M
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)Kingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsPathway BioventuresIronwood Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.